Login / Signup

Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck.

Jennifer L LeddonShuchi GulatiSulsal HaqueCasey AllenSarah PalackdharryMaria MathewsNicky KurtzweilMuhammed Kashif RiazVinita TakiarMisako NagasakaYash PatilChad ZenderAlice TangBrian CervenkaJulie McGrathWolfgang Michael KornBenjamin H HinrichsRoman JandarovNusrat HarunAmmar SukariTrisha Michel Wise-Draper
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Adjuvant nivolumab after salvage surgery in locally recurrent HNSCC is well tolerated and showed improved DFS compared with historical controls.
Keyphrases
  • squamous cell carcinoma
  • early stage
  • minimally invasive
  • coronary artery bypass
  • open label
  • surgical site infection
  • lymph node metastasis
  • percutaneous coronary intervention